Equity Case Study: Precisis AG

EUR 20m Venture Financing

Precisis AG

Venture Financing
September 2021
€ 20 million

Transaction Highlights

  • Precisis is conducting clinical studies to obtain CE mark for the treatment of brain disorders with its next-gen neurostimulation device
  • Precisis mandated FCF to arrange the financing of its clinical studies and commercialization of its medical device to support its growth story
  • Through its automated investor approach, FCF has successfully synchronized the approach and coordination of > 400 global blue-chip investors (i.e. with AUM > USD 1bn) and to the largest strategic MedTech acquirers who have conducted detailed due diligence
  • Having successfully received term sheets with different transaction structures, FCF advised Precisis on the transaction options that best fit to the Company’s growth plans and managements’ / shareholders’ interests
  • Precisis has eventually chosen for a EUR 20m venture financing from Cochlear Ltd., the global leader in implantable hearing solutions
  • The collaboration will leverage Precisis’ demonstrated ability to trigger a paradigm shift in brain stimulation and benefit from Chochlear’s expertise in the stimulation field and strong commercial network

FCF’s Role in the Transaction

  • Professional preparation of investment documents, strategic positioning of Precisis and fine-tuning of the equity story
  • Development of an in-depth, integrated financial model, including sales forecasting based on a bottom-up market model
  • Intelligent investor selection based on a proprietary investor database and intelligent search algorithm
  • Automated outreach and streamlining of > 400 relevant international venture capital, strategic and family office investors
  • Coordination and moderation of over 75 management and follow-up calls
  • Efficient process management through support in managing the due diligence process, preparation of several financial documents and providing capacities to the management (FCF as external finance department)
  • Term sheet structuring and negotiation including support of the closing process

If you are interested in exploring funding opportunities, please contact us: